THE COVID-19 chapter of the Australian Immunisation Handbook has been updated to include new vaccine formulations and the latest information on immunogenicity and adverse events.
The outdated formulation Comirnaty XBB.1.5 (Pfizer) has been removed, and information about Comirnaty LP.8.1 added.
Factual and editorial updates classify adverse events based on age groups rather than individual vaccine products, as well as providing the most recent data on immunogenicity, efficacy and effectiveness of Comirnaty JN.1 and JN.1-derived sublineage formulations where available.
Read more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Dec 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Dec 25
